179 related articles for article (PubMed ID: 10907740)
1. Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione.
Lemma K; Berglund J; Farrell N; Elding LI
J Biol Inorg Chem; 2000 Jun; 5(3):300-6. PubMed ID: 10907740
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and mechanism for reduction of the anticancer prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by thiols.
Lemma K; Shi T; Elding LI
Inorg Chem; 2000 Apr; 39(8):1728-34. PubMed ID: 12526561
[TBL] [Abstract][Full Text] [Related]
3. Reduction of some Pt(IV) complexes with biologically important sulfur-donor ligands.
Jovanović S; Petrović B; Bugarčić ŽD; van Eldik R
Dalton Trans; 2013 Jun; 42(24):8890-6. PubMed ID: 23657491
[TBL] [Abstract][Full Text] [Related]
4. L-selenomethionine reduces platinum(IV) anticancer model compounds at strikingly faster rates than L-methionine.
Huo S; Dong J; Shen S; Ren Y; Song C; Xu J; Shi T
Dalton Trans; 2014 Nov; 43(41):15328-36. PubMed ID: 25075569
[TBL] [Abstract][Full Text] [Related]
5. Kinetics and mechanism of reactions of the drug tiopronin with platinum(IV) complexes.
Huo S; Shi H; Liu D; Shen S; Zhang J; Song C; Shi T
J Inorg Biochem; 2013 Aug; 125():9-15. PubMed ID: 23665090
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies.
Huo S; Shen S; Liu D; Shi T
J Phys Chem B; 2012 Jun; 116(22):6522-8. PubMed ID: 22574871
[TBL] [Abstract][Full Text] [Related]
7. Spectroscopic, kinetic, and theoretical analyses of oxidation of dl-ethionine by Pt(IV) anticancer model compounds.
Wang J; Yao H; Lu T; Dong J; Xu B; Liu Y; Liu C; Zhou L; Shi T
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Dec; 223():117328. PubMed ID: 31295632
[TBL] [Abstract][Full Text] [Related]
8. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
9. Reduction of ormaplatin and cis-diamminetetrachloroplatinum(iv) by ascorbic acid and dominant thiols in human plasma: kinetic and mechanistic analyses.
Dong J; Ren Y; Huo S; Shen S; Xu J; Tian H; Shi T
Dalton Trans; 2016 Jul; 45(28):11326-37. PubMed ID: 27327648
[TBL] [Abstract][Full Text] [Related]
10. Photoactivatable platinum complexes.
Bednarski PJ; Mackay FS; Sadler PJ
Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and mechanism for reversible chloride transfer between mercury(II) and square-planar platinum(II) chloro ammine, aqua, and sulfoxide complexes. Stabilities, spectra, and reactivities of transient metal-metal bonded platinum-mercury adducts.
Gröning O; Sargeson AM; Deeth RJ; Elding LI
Inorg Chem; 2000 Sep; 39(19):4286-94. PubMed ID: 11196924
[TBL] [Abstract][Full Text] [Related]
12. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
13. Platinum(II) catalysis and radical intervention in reductions of platinum(IV) antitumor drugs by ascorbic acid.
Weaver EL; Bose RN
J Inorg Biochem; 2003 Jul; 95(4):231-9. PubMed ID: 12818793
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of the glutathione species towards the reduction of ormaplatin (or tetraplatin).
Dong J; Huo S; Shen S; Xu J; Shi T; Elding LI
Bioorg Med Chem Lett; 2016 Sep; 26(17):4261-6. PubMed ID: 27481559
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
Dedon PC; Borch RF
Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
[TBL] [Abstract][Full Text] [Related]
16. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ
Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408
[TBL] [Abstract][Full Text] [Related]
17. Studies of interactions between platinum(II) complexes and some biologically relevant molecules.
Petrović D; Stojimirović B; Petrović B; Bugarcić ZM; Bugarcić ZD
Bioorg Med Chem; 2007 Jun; 15(12):4203-11. PubMed ID: 17412597
[TBL] [Abstract][Full Text] [Related]
18. Kinetic and mechanistic study of the Pt(II) versus Pt(IV) effect in the platinum-mediated nitrile-hydroxylamine coupling.
Luzyanin KV; Kukushkin VY; Ryabov AD; Haukka M; Pombeiro AJ
Inorg Chem; 2005 Apr; 44(8):2944-53. PubMed ID: 15819582
[TBL] [Abstract][Full Text] [Related]
19. Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma.
Liu Y; Tian H; Xu L; Zhou L; Wang J; Xu B; Liu C; Elding LI; Shi T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726728
[TBL] [Abstract][Full Text] [Related]
20. Effects of geometric isomerism in dinuclear antitumor platinum complexes on their interactions with N-acetyl-L-methionine.
Oehlsen ME; Hegmans A; Qu Y; Farrell N
J Biol Inorg Chem; 2005 Aug; 10(5):433-42. PubMed ID: 16091934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
